5-(2-Benzothiazolyl)-3-ethyl-2-[2-(methylphenylamino)ethenyl]-1-phenyl-1H-benzimidazolium iodide
SIGMA/B2311 - ≥98% (HPLC)
CAS Number: 681281-88-9
Empirical Formula (Hill Notation): C31H27IN4S
Molecular Weight: 614.54
MDL Number: MFCD00570739
Linear Formula: C31H27IN4S
Product Type: Chemical
| assay | ≥98% (HPLC) |
| color | yellow to orange |
| form | powder |
| InChI | 1S/C31H27N4S.HI/c1-3-34-2 |
| InChI key | NAYRELMNTQSBIN-UHFFFAOYSA |
| Quality Level | 100 ![]() |
| SMILES string | [I-].CC[n+]1c(C=CN(C)c2 |
| solubility | DMSO: 5 mg/mL, clear |
| storage temp. | 2-8°C |
| Biochem/physiol Actions: | 5-(2-Benzothiazolyl)-3-et<WBR>hyl-2-[2-(methylphenylami<WBR>no)-ethenyl]-1-phenyl-1H-<WBR>benzimidazolium, or Akt Inhibitor IV, is a cell-permeable benzimidazole compound that inhibits Akt phosphorylation/activatio<WBR>n by targeting the ATP binding site of a kinase upstream of Akt, but downstream of PI3K. Shown to block Akt-mediated FOXO1a nuclear export (IC<SUB>50</SUB> = 0.625μM) and cell proliferation (IC<SUB>50</SUB> < 1.25μM) in 786-O cells. Unlike phosphatidylinositol analog-based Akt inhibitors, this inhibitor does not affect PI3K. |
| Biochem/physiol Actions: | 5-(2-Benzothiazolyl)-3-et |
| Features and Benefits: | This compound is featured on the PKB/Akt page of the Handbook of Receptor Classification and Signal Transduction. To browse other handbook pages, click here . |
| Packaging: | 5 mg in glass bottle |
| Hazard Codes | Xi |
| Risk Statements | 36/37/38 |
| Safety Statements | 26-36 |
| RIDADR | NONH for all modes of transport |
| WGK Germany | WGK 3 |
| Flash Point(F) | Not applicable |
| Flash Point(C) | Not applicable |
| Purity | ≥98% (HPLC) |
| Storage Temp. | 2-8°C |
| UNSPSC | 12352200 |

